Revidia Therapeutics, Inc.

Biotechnology company · Lamoine, Maine, United States

Revidia Therapeutics, Inc. is a biotechnology company headquartered in Lamoine, Maine, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Revidia Therapeutics at a glance

Typebiotechnology company

HeadquartersLamoine, Maine, United States

Employees (self-reported, 2024)2

What does Revidia Therapeutics do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.9 million in total (2017 to 2024). NIH funding came from the National Heart, Lung, and Blood Institute.

Frequently asked questions about Revidia Therapeutics

Where is Revidia Therapeutics headquartered?

Revidia Therapeutics, Inc. is headquartered in Lamoine, Maine, United States.

What does Revidia Therapeutics do?

Revidia Therapeutics, Inc. is a biotechnology company.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences